Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Price Passes Above 50 Day Moving Average – Here’s What Happened

Shares of Ono Pharmaceutical Co. (OTCMKTS:OPHLF) passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $11.48 and traded as high as $11.68. Ono Pharmaceutical shares last traded at $10.27, with a volume of 1,000 shares changing hands.

Ono Pharmaceutical Trading Down 14.8%

The company has a debt-to-equity ratio of 0.13, a current ratio of 2.99 and a quick ratio of 2.44. The firm has a fifty day moving average price of $11.48 and a 200-day moving average price of $11.02. The company has a market capitalization of $4.82 billion, a P/E ratio of 16.56 and a beta of 0.19.

Ono Pharmaceutical (OTCMKTS:OPHLF) last released its earnings results on Monday, August 4th. The company reported $0.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.08). Ono Pharmaceutical had a return on equity of 5.47% and a net margin of 8.75%.The firm had revenue of $886.27 million during the quarter, compared to analysts’ expectations of $827.29 million.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.